Augmentation Cystoplasty Using an Autologous Neo-Bladder

Stopped early · Phase 2

Conditions studied: Neurogenic Bladder

In brief

Subjects with neurogenic bladder secondary to spina bifida refractory to medical treatment will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will significantly increase bladder compliance.

Key facts

Study ID

NCT00419120

Run by

Tengion

People needed

10

Starts

2006-12-01

Expected to finish

2011-04-01

Last updated by the study team

2015-11-30

Who can join

Age: 3 and older, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• subjects with neurogenic bladders secondary to myleodysplasia

You may not qualify if…

• prior augment procedures
• recent urologic surgery
• requires concomitant urologic intervention

Where it is running

• Boston Childrens Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.